Filter Results:
(1,253)
Show Results For
- All HBS Web
(1,253)
- People (5)
- News (177)
- Research (922)
- Events (6)
- Multimedia (12)
- Faculty Publications (754)
Show Results For
- All HBS Web
(1,253)
- People (5)
- News (177)
- Research (922)
- Events (6)
- Multimedia (12)
- Faculty Publications (754)
- 28 Apr 2010
- Research & Ideas
Earth Day Reflections
opportunity to engage in a virtual dialogue on these matters. Some major corporations are starting to take the lead in this effort, including United Technologies Corporation, Philips (the Dutch electronics and health care giant), the German chemical company BASF, and... View Details
Keywords: by Staff
- Research Summary
Overview
Dr. Crawford conducts research on innovation in the energy industry, with a special focus on emerging business models. She is developing several cases for the EC course, "21st Century Energy," that specifically examine innovations at the interface of IT and Energy — ... View Details
Keywords: Electricity; Prosumer; Smart Grid; Blockchain; Microgrid; Electric Vehicles; Batteries; Energy Storage; Ride-sharing; Smart Cities; Smart Buildings; Smart Meters; Demand Response; "GMOs,"; Corporate Accountability; Responsibilities To Society; Environmental And Social Sustainability; Leadership & Corporate Accountability; Competitive Strategy; Innovation Strategy; Disruptive Innovation; Research and Development; Leadership; Environmental Sustainability; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Europe; Asia; United States
- January 2007 (Revised January 2007)
- Background Note
Note on the U.S. Food and Drug Administration
By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. View Details
Keywords: Health; Governance Compliance; Policy; Product Development; Government and Politics; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Higgins, Robert F., Richard G. Hamermesh, and Virginia Fuller. "Note on the U.S. Food and Drug Administration." Harvard Business School Background Note 807-050, January 2007. (Revised January 2007.)
- 24 Feb 2009
- First Look
First Look: February 24, 2009
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=909036 Esser & Ackermann at Mannesmann Harvard Business School Case 209-095 No abstract is available at this time. Purchase this case:... View Details
Keywords: Martha Lagace
- July 2014 (Revised February 2015)
- Teaching Note
Johnson & Johnson: The Promotion of Wellness
By: John A. Quelch
The chief medical officer of Johnson & Johnson (J & J) is reflecting on forty years of sustained efforts by the company to improve employee wellness. The case reviews J & J's multiple wellness initiatives and efforts to measure their effectiveness. It also invites... View Details
Keywords: Empoylee Wellness Programs; Human Resource Management; Corporate Management Strategy; Employee Engagement; Human Resources; Management; Organizations; Performance; Personal Development and Career; Programs; Strategy; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; North and Central America; Europe; Asia
- 27 May 2009
- First Look
First Look: May 27, 2009
Case 509-048 The case describes the effort of Merck, a global leader in pharmaceuticals, in making available its medicines to the poor. The challenge for the company (or for that matter, any pharmaceutical company) is how to integrate its... View Details
Keywords: Martha Lagace
- 2022
- Book
Les multinationales suisses dans l'arène politique (1942–1993) [Swiss Multinationals in the Political Arena (1942–1993)]
By: Sabine Pitteloud
En décembre 2020, les Suisses votaient sur l’initiative populaire « pour des multinationales responsables ». Cet épisode récent a rappelé que la régulation de l’activité des sociétés multinationales fait l’objet de luttes politiques, auxquelles participent les... View Details
Keywords: Multinational Enterprise; Multinational Companies; Multinational Corporations; Lobbying; Business & Government Relations; Labor Relations; Relocation; Offshoring And Outsourcing; Corporate Regulation; Transnational Regulation; Multinational Firms and Management; Business and Government Relations; Governing Rules, Regulations, and Reforms; International Relations; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Switzerland
Pitteloud, Sabine. Les multinationales suisses dans l'arène politique (1942–1993) [Swiss Multinationals in the Political Arena (1942–1993)]. Genève, Suisse: Librairie Droz, 2022, French ed.
- October 2020 (Revised April 2022)
- Case
When Institutions Fail: HIV/AIDS in the 1980s
By: Tom Nicholas and Christian Godwin
During the early 1980s, young gay men in urban centers such as San Francisco and New York City began contracting a mysterious illness that would come to be known as HIV/AIDS. A diagnosis meant almost certain death, with a less than 1% survival rate. Conflicting... View Details
Keywords: Ethics; Policy; Government and Politics; Health Pandemics; History; Rights; Media; Organizations; Business and Community Relations; Religion; Social Psychology; Identity; Prejudice and Bias; Social Issues; Public Opinion; Pharmaceutical Industry; Biotechnology Industry; Health Industry; Journalism and News Industry; Media and Broadcasting Industry; Public Administration Industry; United States
Nicholas, Tom, and Christian Godwin. "When Institutions Fail: HIV/AIDS in the 1980s." Harvard Business School Case 821-002, October 2020. (Revised April 2022.)
- 25 Feb 2014
- First Look
First Look: February 25
Laboratories' Proposed Merger with King Pharmaceutical Perry Capital owns shares in King and, to facilitate approval of the merger, buys shares in Mylan, whilst hedging out its economic exposure to Mylan's share price using derivatives.... View Details
Keywords: Sean Silverthorne
- 12 Apr 2010
- Research & Ideas
One Report: Better Strategy through Integrated Reporting
electronics company Philips; the Danish pharmaceutical company Novo Nordisk; the Brazilian cosmetics company Natura; and the U.S.-based technology and aerospace company United Technologies all come to mind. All have done a very good job... View Details
Keywords: by Martha Lagace
- 02 Apr 2013
- First Look
First Look: April 2
care needs to go "beyond the pill" and systematically integrate combinations of treatments. We discuss the implications of this approach for organizational and business models in the pharmaceutical industry. 2006 World Politics... View Details
Keywords: Sean Silverthorne
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
series on AIDS in Africa and how pharmaceutical companies should think about the issues and how they might respond. Sandra Sucher has done a really wonderful case on Gleevec, which is a drug for treating chronic myeloid leukemia. She is... View Details
- 12 Jan 2016
- First Look
January 12, 2016
November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing drug surveillance is the process of monitoring the adverse... View Details
Keywords: Carmen Nobel
- Web
Winners & Success Stories | New Venture Competition
make considerable achievement gains while building their self-confidence. The Company collaborates with parents, schools, community organizations, and local educators to implement programs that will help students succeed in school, and ultimately in life. Potentia... View Details
- 10 Jan 2005
- Research & Ideas
Motivation and the Cross-Sector Alliance
medicines. Furthermore, Chile offers no reimbursements for pharmaceutical expenses, so this tends to add to customers' negative disposition." To respond to this situation, FASA considered a possible collaboration with the Fundación... View Details
- 09 Jan 2007
- First Look
First Look: January 9, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707413 Teva Pharmaceutical Industries, Ltd. Harvard Business School Case 707-441 Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707441 ... View Details
Keywords: Martha Lagace
- 20 Jan 2015
- First Look
First Look: January 20
School Case 514-084 Vision 2020: Takeda and the Vaccine Business In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a... View Details
Keywords: Sean Silverthorne
- 03 Sep 2013
- First Look
First Look: September 3
Research Center: Growing a Joint Research Venture in India Bristol Myers Squibb, a multi-national pharmaceutical company, is seeking to globalize its R&D strategy while managing costs. It has formed a joint venture with an Indian... View Details
Keywords: Sean Silverthorne
- 01 Jul 2008
- First Look
First Look: July 1, 2008
establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate? Purchase... View Details
Keywords: Martha Lagace
- 01 Mar 2014
- News
My HBS Eureka Moment
uncomfortable with the ethnic background of the proponents, who were proposing to start a pharmaceutical company in Mexico. I could never get comfortable, and missed a huge opportunity. The product was the birth control pill." The lesson... View Details